نتایج جستجو برای: human factor ix hfix

تعداد نتایج: 2306245  

Journal: :iranian journal of allergy, asthma and immunology 0
hassan mansouri torghabeh aliakbar pourfathollah mahmood mahmoodian shooshtari zahra rezaie yazdi

many investigations have proved relations between abo blood groups with some diseases and factor viii and von willebrand level in plasma. in this study we investigated a relation between abo blood groups and factor viii and ix inhibitors in 102 patients with haemophilia a and 48 patients with haemophilia b. the assay of inhibitor was done by bethesda method. there were no relation between abo b...

2014
Jeng-Chung Chen Shu-Chiang Lin Wen-Chin Li

This study applied Human Factors Intervention Matrix (HFIX) framework and Analytic Hierarchy Process (AHP) to develop human errors intervention strategy. Our AHP questionnaire,designed based on the 31 incident scenarios that were taken place between 2009 and 2011 and included 72 safety recommendations to reduce specific human errors, was distributed to commercial airlines related personnel and ...

Journal: :Thrombosis research 2007
Lingfei Xu Manxue Mei Mark E Haskins Timothy C Nichols Patricia O'donnell Karyn Cullen Aaron Dillow Dwight Bellinger Katherine P Ponder

INTRODUCTION Gene therapy could prevent bleeding in hemophilia. However, antibodies could inhibit coagulation, while cytotoxic T lymphocytes could destroy modified cells. The immaturity of the newborn immune system might prevent these immune responses from occurring after neonatal gene therapy. MATERIALS AND METHODS Newborn dogs, cats, or mice were injected intravenously with a retroviral vec...

ژورنال: :مجله زیست شناسی ایران 2010
اعظم دالمن امیر امیری یکتا محمدحسین صنعتی پوپک افتخاری یزدی عبدالحسین شاهوردی

تعداد بی شماری از پروتئین های نوترکیب وجود دارند که در شیر بیان می شوند. در این راستا می توان ژن مورد نظر را به منظور بیان در شیر یک حیوان مزرعه ای تحت کنترل عناصر تنظیمی قرار داد. انتقال هسته با استفاده از سلولهای ترانسفکت شده، ابزار کارآیی برای تولید حیوانات تراریخته است. در این مطالعه به منظور تولید بز تراریخته با توانایی ترشح فاکتور ix انعقادی انسانی نوترکیب (rhcfix) در شیر، سازه ژنی(pbc1-h...

2014
Nicolau Brito da Cunha André Murad Giovanni Vianna Elíbio Rech

Background Plants constitute promising systems for the alternative production of valuable recombinant proteins. Recently, ELELYSOTM, an enzymatic drug developed by the Israeli company Protalix Biotherapeutics to treat Type 1 Gaucher’s disease, became the first plant-derived therapeutic product to reach marketable status [1]. This confirms the inherent potential of plant systems for the large-sc...

Journal: :Blood 1999
J N Lozier M E Metzger R E Donahue R A Morgan

We have determined the 2905 nucleotide sequence of the rhesus macaque factor IX complementary DNA (cDNA) and found it to be greater than 95% identical to that of the human factor IX cDNA. The cDNA has a large 3' untranslated region like the human cDNA, but unlike the human cDNA has two polyadenylation sites 224 nucleotides apart that are used for transcription of the messenger RNA. The deduced ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1988
D St Louis I M Verma

Mouse primary skin fibroblasts were infected with a recombinant retrovirus containing human factor IX cDNA. Bulk infected cells capable of synthesizing and secreting biologically active human factor IX protein were embedded in collagen, and the implant was grafted under the epidermis. Sera from the transplanted mice contain human factor IX protein for at least 10-12 days. Loss of immunoreactive...

2005
Katherine Parker Ponder

Hemophilia A has an incidence of 1 in 5000 males and is due to deficiency of hFVIII. The mainstay of treatment is intravenous injection of hFVIII protein prophylactically or during bleeding, which is expensive and inconvenient. Identification of alternative treatments would be a very important advance. Gene therapy for hemophilia A involves transfer of a FVIII gene into cells that can secrete f...

Journal: :medical journal of islamic republic of iran 0
s nasiri from the department of research and development, blood research and fractionation co., tehran, and the *department of virology, tarbiat modarres university, tehran, i.r. iran. h rezvan k mousavi mh roostaei

in this study, anion-exchange chromatography was used to purify factor vii and factor ix from prothrombin complex (ppsb), which contains coagulation factors ii, vii, ix and x. for this purpose, deae-sepharose cl-6b gel , pharmacia column xk-26 , high flow rate and two stepwise gradients with phosphate citrate buffer were used. the yield of the two lyophylized products, factor vii and factor ix ...

Journal: :Journal of Clinical Investigation 1978

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید